WALTHAM, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (RDUS), today announced that Company management will be attending and participating in the 2019 Credit Suisse Global Healthcare Conference in London on Tuesday, March 5, 2019 and hosting one-on-one meetings with investors on that date.
Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. For more information, please visit www.radiuspharm.com.
Investor Relations Contact:
Elhan Webb, CFA